BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22855058)

  • 21. Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target.
    Liu Y; Luo G; He D
    Bioengineered; 2019 Dec; 10(1):133-141. PubMed ID: 31055998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLF6mRNA expression in primary hepatocellular carcinoma.
    Wang S; Chen X; Zhang W; Qiu F
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(6):585-7. PubMed ID: 15791848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes.
    Mühlbauer KR; Gröne HJ; Ernst T; Gröne E; Tschada R; Hergenhahn M; Hollstein M
    Br J Cancer; 2003 Aug; 89(4):687-90. PubMed ID: 12915879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
    Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Krüppel-like factor 6 is a co-activator of NF-κB that mediates p65-dependent transcription of selected downstream genes.
    Zhang Y; Lei CQ; Hu YH; Xia T; Li M; Zhong B; Shu HB
    J Biol Chem; 2014 May; 289(18):12876-85. PubMed ID: 24634218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function.
    Rodríguez E; Aburjania N; Priedigkeit NM; DiFeo A; Martignetti JA
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
    Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
    Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of the oncogene PTTG1 via the KLF6 tumor suppressor during induction of myeloid differentiation.
    Chen PY; Yen JH; Kao RH; Chen JH
    PLoS One; 2013; 8(8):e71282. PubMed ID: 23977008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations and Krüppel-like factor 6 (KLF6) expression levels in breast cancer.
    Ozdemir F; Koksal M; Ozmen V; Aydin I; Buyru N
    Tumour Biol; 2014 Jun; 35(6):5219-25. PubMed ID: 24519062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.
    Miele L; Beale G; Patman G; Nobili V; Leathart J; Grieco A; Abate M; Friedman SL; Narla G; Bugianesi E; Day CP; Reeves HL
    Gastroenterology; 2008 Jul; 135(1):282-291.e1. PubMed ID: 18515091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.
    Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP
    PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
    Tan Y; Chen L; Li S; Hao H; Zhang D
    Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.
    Botella LM; Sanz-Rodriguez F; Komi Y; Fernandez-L A; Varela E; Garrido-Martin EM; Narla G; Friedman SL; Kojima S
    Biochem J; 2009 Apr; 419(2):485-95. PubMed ID: 19076057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kruppel-like factor 6 (KLF6) affects the promoter activity of the alpha1-proteinase inhibitor gene.
    Chiambaretta F; Nakamura H; De Graeve F; Sakai H; Marceau G; Maruyama Y; Rigal D; Dastugue B; Sugar J; Yue BY; Sapin V
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):582-90. PubMed ID: 16431954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel regulator of human villous trophoblast fusion: the Krüppel-like factor 6.
    Racca AC; Ridano ME; Camolotto S; Genti-Raimondi S; Panzetta-Dutari GM
    Mol Hum Reprod; 2015 Apr; 21(4):347-58. PubMed ID: 25537765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
    Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
    J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
    Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
    RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
    Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.